Skip to main navigation
  Menu

ASLAN Pharmaceuticals

  • Pipeline
  • Our Team
  • Investor Relations
  • News & Publications
  • Contact
EN
english中文

Investor Relations

Investor Relations

  • Investor Home
  • Corporate Information
  • Stock Information
  • News & Events
  • Financial Information
    • SEC Filings
    • Quarterly Results
    • Analyst Coverage
  • Shareholder Services

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Alerts sign up

Required fields denoted by an asterisk ().
Alert type

Analyst Coverage

Analyst Coverage

Firm Analyst
BTIG
Robert Hazlett
H.C. Wainwright & Co.
Raghuram Selvaraju, Ph.D.
Jefferies
Maury Raycroft
Piper Sandler
Edward Tenthoff

ASLAN Pharmaceuticals is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding ASLAN Pharmaceuticals's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of ASLAN Pharmaceuticals or its management. ASLAN Pharmaceuticals does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Shareholder Tools

  • Print Page

    Print Page

  • RSS Feeds

    RSS Feeds

  • E-mail Alerts

    E-mail Alerts

Company

  • Pipeline
  • Our Team
  • Investor Relations
  • News & Publications
  • Contact
  • Terms and Conditions

Careers

For more information on employment opportunities at ASLAN, please contact us at careers@aslanpharma.com

Contact Us

Singapore Headquarters
83 Clemenceau Avenue
#12-03 UE Square
Singapore 239920
Tel: +65 6222 4235
Fax: +65 6225 2419

contact@aslanpharma.com